These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 698929)

  • 81. Profound hypocalcaemia associated with oestrogen treatment of carcinoma of the prostate.
    Harley HA; Mason R; Phillips PJ
    Med J Aust; 1983 Jul; 2(1):41-2. PubMed ID: 6865830
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Cellular reactions of immunocytes against prostate carcinoma and their clinical relevance (author's transl)].
    Stöber U
    Urol Int; 1979; 34(1):1-10. PubMed ID: 570753
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Prostatic adenocarcinoma with endometrioid features treated with oestrogen.
    Matsuda T; Hida S; Yoshida O
    Br J Urol; 1989 Sep; 64(3):317-8. PubMed ID: 2804571
    [No Abstract]   [Full Text] [Related]  

  • 84. Immunostaging in carcinoma of prostate.
    Guinan PD; Ablin RJ; Rios ER; Sheik HA; Bush IM
    Urology; 1976 Feb; 7(2):178-80. PubMed ID: 1108352
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Cell-mediated immunity in patients with endometrial adenocarcinoma.
    Menczer J; Dor J; Soffer Y; Serr DM
    Gynecol Oncol; 1978 Jun; 6(3):223-8. PubMed ID: 669439
    [No Abstract]   [Full Text] [Related]  

  • 86. Immuno suppression in patients with cancer undergoing 137Cs therapy.
    Sen Gupta SK; Talukdar G; Sen Gupta KP
    Indian J Cancer; 1979 Mar; 16(1):51-4. PubMed ID: 540951
    [No Abstract]   [Full Text] [Related]  

  • 87. Oestrogen therapy and serum cortisol in carcinoma of the prostate.
    Morales A; Kraus AS; Bruce AW
    Br J Urol; 1975 Jun; 47(3):283-6. PubMed ID: 1095102
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Letter: Diethylstilbestrol exposure and lymphocytic impairment.
    Ablin RJ; Bruns GR; Guinan PD; Bush IM
    JAMA; 1974 Sep; 229(14):1863. PubMed ID: 4479169
    [No Abstract]   [Full Text] [Related]  

  • 89. Cancer, immunological surveillance, and 2 -globulin.
    Ablin RJ
    Lancet; 1972 Oct; 2(7782):874-5. PubMed ID: 4116576
    [No Abstract]   [Full Text] [Related]  

  • 90. [Changes in fine structure of prostate carcinoma after treatment with phosphorylized diethylstilbesterol].
    JACOB H; ROTHAUGE CF
    Z Urol; 1956; 49(5):301-7. PubMed ID: 13361401
    [No Abstract]   [Full Text] [Related]  

  • 91. [Diethylstilbestrol diphosphate in prostate cancer therapy].
    DRUCKREY H; KAISER K
    Dtsch Med Wochenschr; 1956 Jul; 81(27):1084-6. PubMed ID: 13344071
    [No Abstract]   [Full Text] [Related]  

  • 92. Endocrine function and immunity.
    Br Med J (Clin Res Ed); 1981 Jul; 283(6284):88-9. PubMed ID: 6789947
    [No Abstract]   [Full Text] [Related]  

  • 93. Influence of "central" and "peripheral" estrogen injection on several parameters of immune homeostasis.
    Kuz'menko VN; Bordyushkov YuN
    Neurosci Behav Physiol; 1986; 16(2):165-8. PubMed ID: 3528913
    [No Abstract]   [Full Text] [Related]  

  • 94. Further evaluation of the effect of estrogen on tumor-associated immunity in prostatic cancer.
    Ablin RJ; Bhatti RA; Guinan PD
    Isr J Med Sci; 1979 Jan; 15(1):9-11. PubMed ID: 422345
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Modulatory effects of oestrogen on immunological responsiveness. II. Suppression of tumour-associated immunity in patients with prostatic cancer.
    Ablin RJ; Bhatti RA; Guinan PD; Khin W
    Clin Exp Immunol; 1979 Oct; 38(1):83-91. PubMed ID: 93529
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Arming of normal leukocytes with sera from patients with adenocarcinoma of the prostate.
    Bhatti RA; Ablin RJ; Condoulis W; Guinan PD
    Cancer Res; 1979 Sep; 39(9):3328-31. PubMed ID: 476662
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Possible suppression of host resistance by estrogen therapy for prostatic cancer.
    Ablin RJ
    Can Med Assoc J; 1976 Dec; 115(11):1082-4. PubMed ID: 1000436
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effect of estrogen on tumor-associated immunity in patients with adenocarcinoma of the prostate.
    Ablin RJ; Bhatti RA; Guinan PD
    Cancer Res; 1978 Nov; 38(11 Pt 1):3702-6. PubMed ID: 698929
    [TBL] [Abstract][Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.